Stem Cell Aggregate Stability via Heparin and PEG

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for large-scale production of human pluripotent stem cells in bioreactors face challenges such as cell clumping, shear stress, and batch-to-batch variability, which affect aggregate stability and pluripotency, leading to heterogenous cell populations and reduced clinical safety and potency.

Innovation Solution

The use of a culture media comprising heparin sodium salt (HS) and polyethylene glycol (PEG) in combination with other additives like polyvinyl alcohol (PVA) and dextran sulfate (DS) to maintain and modulate aggregate stability, preventing unwanted cell adhesion and promoting controlled aggregate growth, thereby enhancing pluripotency and differentiation efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If suspension bioreactor culture is used for large-scale hPSC production, then productivity and scalability are improved, but aggregate stability and pluripotency maintenance deteriorate due to shear stress and cell clumping

Engineering Contradiction:

Improvelarge-scale production capacityVSAvoidaggregate stability

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent introduces PEG and HS as intermediary substances that mediate between the mechanical stress of bioreactor agitation and the cellular aggregates. PEG acts as a protective coating around aggregates, reducing direct shear stress impact, while HS stabilizes aggregate structure through molecular interactions, enabling large-scale culture without compromising aggregate integrity

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent optimizes multiple parameters including PEG concentration (0.1-10% w/v), HS concentration (0.01-1 µg/mL), aggregate size (50-200 µm), and bioreactor agitation speed (50-200 rpm) to achieve the optimal balance between maintaining aggregate stability and enabling scalable production. These parameter adjustments allow transition from small-scale to large-scale culture while preserving pluripotency

Inventive Principle:

Principle #35Parameter changes

2Quantity of substance

If agitation speed is increased to enhance mixing and nutrient distribution, then mass transfer is improved, but shear stress increases causing aggregate breakage and cell death

Engineering Contradiction:

Improvenutrient distribution efficiencyVSAvoidshear stress

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies PEG as a protective cushioning layer around cell aggregates before they are exposed to bioreactor agitation. This pre-protection mechanism allows the aggregates to withstand higher agitation speeds and improved mixing conditions without suffering shear stress damage, enabling better nutrient distribution while maintaining aggregate integrity

Inventive Principle:

Principle #11Beforehand cushioning (Prior cushioning)

3Quantity of substance

If aggregate size is increased to improve cell capacity, then cell production capacity is enhanced, but aggregate heterogeneity increases leading to batch-to-batch variability

Engineering Contradiction:

Improvecell capacity per aggregateVSAvoidbatch-to-batch consistency

Core Design Contradiction:

Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent implements monitoring and control mechanisms that track aggregate size distribution and adjust culture conditions accordingly. By measuring aggregate characteristics and providing feedback to control agitation speed, PEG concentration, and other parameters, the system maintains consistent aggregate size (50-200 µm) and composition across batches, ensuring manufacturing precision while preserving cell capacity

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively maintains aggregate stability and pluripotency, reduces batch-to-batch variability, and allows for controlled aggregate size and growth, improving the reproducibility and clinical quality of stem cell cultures.

Implementation Method 1

reducing shear stress by decreasing surface tension

Methodology Applied

Scientific EffectSurface tension reduction: Surfactant

Implementation Method 2

enhancing extracellular matrix and cell membrane interaction

Methodology Applied

Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS20250011726A1Methods and compositions for maintaining aggregate stability and pluripotency of stem cells

Publication Date: 2025.01.09 TRAILHEAD BIOSYSTEMS INC

AI summary

Methods for maintaining aggregate stability and pluripotency of human stem cells are provided using chemically-defined culture media that includes heparin sodium salt and polyethylene glycol. Methods of modulating aggregate size and/or stability using chemically-defined culture media are also provided. The methods can be used with, for example, induced pluripotent stem cells or embryonic stem cells. Culture media and kits are also provided.